首页 | 本学科首页   官方微博 | 高级检索  
检索        

雷贝拉唑联合莫沙必利治疗返流性食管炎疗效观察
引用本文:刘黎霞.雷贝拉唑联合莫沙必利治疗返流性食管炎疗效观察[J].四川医学,2009,30(11):1747-1748.
作者姓名:刘黎霞
作者单位:四川省人民医院草堂医院消化内科,四川,成都,610071
摘    要:目的观察雷贝拉唑联合莫沙必利治疗返流性食管炎的临床疗效。方法68例返流性食管炎患者采用随机方法分成两组,每组34例;Ⅰ组应用雷贝拉唑联合枸橼酸莫沙必利;Ⅱ组单用雷贝拉唑,评价其临床疗效。结果68例返流性食管炎患者完成4周治疗,Ⅰ组、Ⅱ组症状缓解总有效率分别为94.1%(32/34),70.6%(24/34);Ⅰ组总有效率优于Ⅱ组(P〈0.05)。内镜下缓解情况,Ⅰ组、Ⅱ组有效率分别为90%(18/20)、53.3%(8/15);Ⅰ组有效率优于Ⅱ组(P〈0.05)。结论雷贝拉唑联合枸橼酸莫沙必利治疗返流性食管炎临床改善迅速,临床疗效优于单用雷贝拉唑。

关 键 词:返流性食管炎  雷贝拉唑  莫沙必利

Observation on therapeutic effect of rabeprazole and mosapride curing reflux esophagitis
LIU Li-xia.Observation on therapeutic effect of rabeprazole and mosapride curing reflux esophagitis[J].Sichuan Medical Journal,2009,30(11):1747-1748.
Authors:LIU Li-xia
Institution:LIU Li-xia.( Caotang Hospital, The People's Hospital of Sichuan , Chengdu , Sichuan 610071, China )
Abstract:Objective To observation the efficacy of rabeprazole and mosapride in the treatment of reflux esophagitis (RE). Methods 68 cases of RE was randomized to 2 groups : group Ⅰ ,group Ⅱ with 34 cases in each group. Groups Ⅰ were treated with rabeprazole and mosapride;groups Ⅱ were treated with rabeprazole single. Results 68 cases of RE were treated for 4 weeks. The total effective rate were 94. 1% (32/34) ,70. 6% (24/34). Group Ⅰ was higher than group Ⅱ( P〈0. 05 ). The healing rate of esophageal mucosal lesion in group Ⅰ was higher than that of group Ⅱ( P〈0. 05). Conclusion The efficacy of rabeprazole and mosapride in the treatment of RE is better than that of rabeprazole single.
Keywords:reflux esophagitis  rabeprazole  mosapride
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号